TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease.
Overview
- Cell Death & Biomedicine Lab, Center for Biomedicine, Universidad Mayor, Santiago, Chile
- Translational Neurobiology Lab, Center for Integrative Biology, Universidad Mayor, Santiago, Chile
- Center for Geroscience, Brain Health and Metabolism, Santiago, Chile
- Center for Integrative Biology, Universidad Mayor, Santiago, Chile
- Department of Neurology, The University of Texas Health Science Center at Houston, Houston, USA
- Autophagy and Neuroprotection Lab, Center for Biomedicine, Universidad Mayor, Santiago, Chile
- Resilient Aging Lab, Institute for Nutrition & Food Technology (INTA), Universidad de Chile, Santiago, Chile
- Sorbonne Université, Institut du Cerveau—ICM, Paris, France
- Center for Applied Nanotechnology, Universidad Mayor, Santiago, Chile
- Centro de Biotecnología Vegetal, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile
- Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad Andrés Bello, Santiago, Chile
- Center for Resilience, Adaptation and Mitigation, Universidad Mayor, Temuco, Chile
Abstract
The core pathological hallmark of Parkinson’s disease (PD) is the progressive degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNpc), driven by misfolding and aggregation of a-synuclein (aSyn) into Lewy bodies. This triggers severe cellular dysfunction, including endoplasmic reticulum (ER) stress and the dysregulation of the unfolded protein response (UPR). TMBIM6, an anti-apoptotic ER protein, inhibits the UPR sensor IRE1a. Although TMBIM6 exhibits neuroprotective effects in neurological disorders, its role in PD-related DAergic neuron survival remains unknown. We report that TMBIM6 mRNA is increased in cellular models exposed to 6-hydroxydopamine (6-OHDA), rotenone, or aSyn preformed fibrils (PFFs), whereas TMBIM6 protein levels are elevated in postmortem PD SNpc, indicating translational relevance. Modulating TMBIM6 expression in DAergic cells and primary neurons showed that knockdown increased aSyn toxicity, while overexpression is protective. Single-cell RNA-seq analysis of PD SN revealed selective disruption of TMBIM6 co-expression with key UPR effectors (HSPA5, ERN1, and XBP1), and reduced TMBIM6 levels in vulnerable DAergic neurons. Mechanistically, TMBIM6 directly binds IRE1a, and aSyn PFFs disrupt this complex, leading to IRE1a activation; genetic or pharmacological IRE1a inhibition prevented cell death in TMBIM6-deficient cells. In vivo, TMBIM6 downregulation in Drosophila melanogaster worsens rotenone-induced DAergic neuron degeneration and motor impairments, while adeno-associated virus (AAV)-mediated TMBIM6 overexpression in mice improves motor function and neuron survival. Our results demonstrate that TMBIM6 modulates ER stress responses, promoting DAergic neuron survival by regulating IRE1a activity. Consequently, the TMBIM6/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE8397, at NCBI GEO; found in the text, “In silico TMBIM6 expression analysis”
Data availability
The datasets used and/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Funding: added Agence Nationale de la Recherche: ANR-10-IAIHU06, 10-IAIHU-06, ANR-10; International Brain Research Organization; Institut National de la Santé et de la Recherche Médicale: ANR-10-IAIHU-06; Centre National de la Recherche Scientifique; Agencia Nacional de Investigación y Desarrollo: 1220480, 1240176, 3250688, 11180546, 3240455, 1241229, ID24I10049, 1240785, 1230823, FONDECYT 1240785, 1230980; Fondo de Fomento al Desarrollo Científico y Tecnológico: 1241229
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 20 authors, 5 keywords, 18 MeSH terms, 72 references.
Cite
This paper
Ahumada-Montalva, P., Muñoz-Carvajal, F., Bórquez-Macaya, S., Arévalo-Ramírez, N., Cisternas-Olmedo, M., Jerez, C., Urbina-Muñoz, V., Gomez, W., Urrutia, P. J., Hirsch, E. C., Ahumada, M., Barrias, P., Muñoz-Yañez, C., Herrera-Vásquez, A., Arriagada, G., Woehlbier, U., Calegaro-Nassif, M., Sanhueza, M., Vidal, R. L., & Rojas-Rivera, D. (2026). TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease. Cell death & disease, 17(1), 385. https://
BibTeX
@article{ahumadamontalva
author = {Ahumada-Montalva, Pablo and Muñoz-Carvajal, Francisco and Bórquez-Macaya, Sara and Arévalo-Ramírez, Nohela and Cisternas-Olmedo, Marisol and Jerez, Carolina and Urbina-Muñoz, Valentina and Gomez, Wileidy and Urrutia, Pamela J and Hirsch, Etienne C and Ahumada, Manuel and Barrias, Pablo and Muñoz-Yañez, Camila and Herrera-Vásquez, Ariel and Arriagada, Gloria and Woehlbier, Ute and Calegaro-Nassif, Melissa and Sanhueza, Mario and Vidal, Rene L and Rojas-Rivera, Diego},
title = {{TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease}},
journal = {Cell death \& disease},
year = {2026},
month = apr,
volume = {17},
number = {1},
pages = {385},
publisher = {Nature Publishing Group},
issn = {2041-4889},
doi = {10.1038/
url = {https://
pmid = {41932887},
pmcid = {PMC13061952}
}
RIS
TY - JOUR
AU - Ahumada-Montalva, Pablo
AU - Muñoz-Carvajal, Francisco
AU - Bórquez-Macaya, Sara
AU - Arévalo-Ramírez, Nohela
AU - Cisternas-Olmedo, Marisol
AU - Jerez, Carolina
AU - Urbina-Muñoz, Valentina
AU - Gomez, Wileidy
AU - Urrutia, Pamela J
AU - Hirsch, Etienne C
AU - Ahumada, Manuel
AU - Barrias, Pablo
AU - Muñoz-Yañez, Camila
AU - Herrera-Vásquez, Ariel
AU - Arriagada, Gloria
AU - Woehlbier, Ute
AU - Calegaro-Nassif, Melissa
AU - Sanhueza, Mario
AU - Vidal, Rene L
AU - Rojas-Rivera, Diego
TI - TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease
T2 - Cell death & disease
J2 - Cell Death Dis
PY - 2026
DA - 2026/
VL - 17
IS - 1
SP - 385
SN - 2041-4889
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "TMBIM6 enhances dopaminergic neuron survival by modulating the IRE1a pathway in Parkinson's disease",
"container-title": "Cell death & disease",
"author": [
{
"family": "Ahumada-Montalva",
"given": "Pablo"
},
{
"family": "Muñoz-Carvajal",
"given": "Francisco"
},
{
"family": "Bórquez-Macaya",
"given": "Sara"
},
{
"family": "Arévalo-Ramírez",
"given": "Nohela"
},
{
"family": "Cisternas-Olmedo",
"given": "Marisol"
},
{
"family": "Jerez",
"given": "Carolina"
},
{
"family": "Urbina-Muñoz",
"given": "Valentina"
},
{
"family": "Gomez",
"given": "Wileidy"
},
{
"family": "Urrutia",
"given": "Pamela J"
},
{
"family": "Hirsch",
"given": "Etienne C"
},
{
"family": "Ahumada",
"given": "Manuel"
},
{
"family": "Barrias",
"given": "Pablo"
},
{
"family": "Muñoz-Yañez",
"given": "Camila"
},
{
"family": "Herrera-Vásquez",
"given": "Ariel"
},
{
"family": "Arriagada",
"given": "Gloria"
},
{
"family": "Woehlbier",
"given": "Ute"
},
{
"family": "Calegaro-Nassif",
"given": "Melissa"
},
{
"family": "Sanhueza",
"given": "Mario"
},
{
"family": "Vidal",
"given": "Rene L"
},
{
"family": "Rojas-Rivera",
"given": "Diego"
}
],
"container-title-short":
"volume": "17",
"issue": "1",
"page": "385",
"DOI": "10.1038/
"PMID": "41932887",
"PMCID": "PMC13061952",
"ISSN": "2041-4889",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
3
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-026-39329-2
- FAM120A - a protein inserted in the ALS disease network.Journal: Scientific reportsIn common: mouse, cellular / molecular, 1 reference, 2 authors
- [2] doi:10.1097/md.0000000000040484
- m6A-related genes and their role in Parkinson's disease: Insights from machine learning and consensus clustering.Journal: MedicineIn common: NCBI GEO GSE8397, Parkinson's, cellular / molecular, 1 reference
- [3] doi:10.3390/cells15020137
- BAP31 Modulates Mitochondrial Homeostasis Through PINK1/
Parkin Pathway in MPTP Parkinsonism Mouse Models. Journal: CellsIn common: NCBI GEO GSE8397, Parkinson's, mouse, cellular / molecular - [4] doi:10.1155/2023/6755569
- Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis.Journal: Parkinson's diseaseIn common: NCBI GEO GSE8397, Parkinson's, cellular / molecular
- [5] doi:10.3389/fncel.2023.1288437
- The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.Journal: Frontiers in cellular neuroscienceIn common: NCBI GEO GSE8397, Parkinson's, cellular / molecular
- [6] doi:10.3390/antiox12030582
- Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models.Journal: Antioxidants (Basel, Switzerland)In common: Parkinson's, mouse, cellular / molecular, 3 references
- [7] doi:10.1371/journal.pone.0328682
- Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.Journal: PloS oneIn common: NCBI GEO GSE8397, Parkinson's
- [8] doi:10.1016/j.xcrm.2025.102432 [code]
- Age-(in)dependent altered molecular mechanisms in Parkinson's disease through extracellular vesicle proteome and lipidome.Journal: Cell reports. MedicineIn common: Parkinson's, cellular / molecular, 3 references
- [9] doi:10.3390/toxics14060504
- Molecular Mechanisms of 6PPD and 6PPD-Q Toxicity in Neurodegenerative Diseases: A Network Toxicology and Experimental Validation Study.Journal: ToxicsIn common: NCBI GEO GSE8397, cellular / molecular
- [10] doi:10.14336/ad.2021.1115
- Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets.Journal: Aging and diseaseIn common: NCBI GEO GSE8397
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
